Dearborn Partners’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-69,590
| Closed | -$490K | – | 294 |
|
|
2015
Q1 | $490K | Sell |
69,590
-21,499
| -24% | -$151K | 0.04% | 214 |
|
|
2014
Q4 | $702K | Buy |
91,089
+46,322
| +103% | +$357K | 0.06% | 190 |
|
|
2014
Q3 | $334K | Buy |
44,767
+9,360
| +26% | +$69.8K | 0.03% | 247 |
|
|
2014
Q2 | $343K | Sell |
35,407
-5,095
| -13% | -$49.4K | 0.03% | 239 |
|
|
2014
Q1 | $337K | Buy |
40,502
+6,654
| +20% | +$55.4K | 0.04% | 232 |
|
|
2013
Q4 | $286K | Sell |
33,848
-27,216
| -45% | -$230K | 0.03% | 257 |
|
|
2013
Q3 | $487K | Hold |
61,064
| – | – | 0.06% | 207 |
|
|
2013
Q2 | $471K | Buy |
+61,064
| New | +$471K | 0.07% | 203 |
|